Coronavirus - we're here to help
From how to access your account online, scam awareness, your wellbeing and our community we're here to help.

Skip to main content
  • Register
  • Help
  • Contact us
  • Log in to HL Account

3i Group Plc (III) Ordinary 73 19/22p

Sell:924.40p Buy:924.80p 0 Change: 12.20p (1.30%)
FTSE 100:0.45%
Market closed Prices as at close on 22 September 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:924.40p
Buy:924.80p
Change: 12.20p (1.30%)
Market closed Prices as at close on 22 September 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:924.40p
Buy:924.80p
Change: 12.20p (1.30%)
Market closed Prices as at close on 22 September 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

3i is an investment company which aims to provide its shareholders with quoted access to private equity and infrastructure returns. Currently, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.
Security Weight
Action Sa 37.21%
3i Infrastructure plc Ord NPV 7.00%
Scandlines 4.51%
Cirtec Medical 3.18%
WP AG 2.57%
Q Holding 2.34%
Evernex 2.28%
Royal Sanders 2.08%
Tato 2.06%
Hans Anders 2.06%

Top 10 sectors currently unavailable.

Country Weight
Poland 37.21%
Austria 2.57%
United Kingdom 2.05%
Denmark 1.25%
Netherlands 0.98%

Fee Structure

Management fee of between 1.2% and 1.4% on a tiered basis. Performance fee of 20% of returns above a hurdle of 8% of the growth in NAV per share with a deferral and clawback mechanism in the event of subsequent performance below the hurdle.

Dividend Policy

The Group aims to maintain or grow the dividend each year.

ASSET SPLIT

Total number of holdings: 31.

Trust Manager

Not currently available for this investment trust.

Manager Bio

Not currently available for this investment trust.

Board Of Directors

Simon ThompsonChairman, Simon Borrows, Jonathan Asquith, Caroline Banszky, Coline McConville, Stephen Daintith, Julia Wilson, Alexandra Schaapveld, David Hutchison, Peter Grosch

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.